Fuwen Yuan

Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

AR-targeted therapies sensitize prostate cancer to cuproptosis by transcriptionally activating FDX1.

AR-targeted therapies sensitize prostate cancer to cuproptosis by transcriptionally activating FDX1.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 01, 2026

6''-O-acetylsaikosaponin D targets STAT3-mediated transcriptional remodeling to induce ferroptosis and apoptosis.

6''-O-acetylsaikosaponin D targets STAT3-mediated transcriptional remodeling to induce ferroptosis and apoptosis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 31, 2025

Mapping the application landscape of artificial intelligence in prostate cancer: a global bibliometric analysis.

Mapping the application landscape of artificial intelligence in prostate cancer: a global bibliometric analysis.

Journal: International journal of surgery (London, England)

Published: July 12, 2025

Implicates of PIP5K1α in asthma-related biological processes: insights into mechanisms and therapeutic potential.

Implicates of PIP5K1α in asthma-related biological processes: insights into mechanisms and therapeutic potential.

Journal: Journal of translational medicine

Published: May 19, 2025

Saikosaponin‑D triggers cancer cell death by targeting the PIM1/c-Myc axis to reprogram oncogenic alternative splicing.

Saikosaponin‑D triggers cancer cell death by targeting the PIM1/c-Myc axis to reprogram oncogenic alternative splicing.

Journal: Cell death discovery

Published: May 03, 2025

Emerging implications of N6-methyladenosine in prostate cancer progression and treatment.

Emerging implications of N6-methyladenosine in prostate cancer progression and treatment.

Journal: Cell death discovery

Published: April 18, 2025

Programmable mRNA 3'UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer.

Programmable mRNA 3'UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer.

Journal: Nature biomedical engineering

Published: April 15, 2025

Potential application of nanodelivery systems targeting ELAVL1 in prostate cancer treatment.

Potential application of nanodelivery systems targeting ELAVL1 in prostate cancer treatment.

Journal: Frontiers in oncology

Published: April 10, 2025

Integrative high-throughput studies to develop novel targets and drugs for the treatment of advanced prostate cancer.

Integrative high-throughput studies to develop novel targets and drugs for the treatment of advanced prostate cancer.

Journal: Genes & diseases

Published: February 25, 2025

Programmed Cell Death in Cancer.

Programmed Cell Death in Cancer.

Journal: MedComm

Published: December 12, 2024

Gut Microbiota-Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment.

Gut Microbiota-Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment.

Journal: Cancer research

Published: November 20, 2024

Reynoutria multiflora (Thunb.) Moldenke and its ingredient suppress lethal prostate cancer growth by inducing CDC25B-CDK1 mediated cell cycle arrest.

Reynoutria multiflora (Thunb.) Moldenke and its ingredient suppress lethal prostate cancer growth by inducing CDC25B-CDK1 mediated cell cycle arrest.

Journal: Bioorganic chemistry

Published: June 12, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026